Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes.
Allavena, P
Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes. [electronic resource] - International journal of cancer Jul 1987 - 104-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0020-7136
10.1002/ijc.2910400119 doi
Antineoplastic Agents--therapeutic use
Cell Line
Cell Survival
Colonic Neoplasms--drug therapy
Drug Resistance
Humans
Immunity, Innate
Interleukin-2--pharmacology
Killer Cells, Natural--drug effects
Monocytes--drug effects
Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes. [electronic resource] - International journal of cancer Jul 1987 - 104-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0020-7136
10.1002/ijc.2910400119 doi
Antineoplastic Agents--therapeutic use
Cell Line
Cell Survival
Colonic Neoplasms--drug therapy
Drug Resistance
Humans
Immunity, Innate
Interleukin-2--pharmacology
Killer Cells, Natural--drug effects
Monocytes--drug effects